Gilead Sciences Insider Sells 3,000 Shares

Johanna Mercier, a Gilead Sciences insider, sold 3,000 shares of the company's stock.

Mar. 18, 2026 at 12:40am

Got story updates? Submit your updates here. ›

Gilead Sciences, Inc. (NASDAQ:GILD) insider Johanna Mercier sold 3,000 shares of the firm's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $144.23, for a total transaction of $432,690.00. Following the completion of the transaction, the insider directly owned 131,779 shares of the company's stock, valued at $19,006,485.17.

Why it matters

Insider transactions, such as stock sales, can provide insights into a company's performance and the perspectives of key individuals within the organization. The sale of 3,000 shares by a Gilead Sciences insider may signal changes in the company's outlook or strategy.

The details

Johanna Mercier, a Gilead Sciences insider, sold 3,000 shares of the company's stock on March 16, 2026. The shares were sold at an average price of $144.23, resulting in a total transaction value of $432,690.00. Following the sale, Mercier directly owned 131,779 shares of Gilead Sciences, valued at $19,006,485.17.

  • The stock sale occurred on Monday, March 16, 2026.

The players

Johanna Mercier

A Gilead Sciences insider who sold 3,000 shares of the company's stock.

Gilead Sciences, Inc.

A biopharmaceutical company focused on the discovery, development, and commercialization of medicines in areas of high unmet medical need, with a portfolio anchored by antiviral therapies for HIV and viral hepatitis.

Got photos? Submit your photos here. ›

The takeaway

The sale of 3,000 shares by a Gilead Sciences insider may indicate changes in the company's outlook or strategy, providing investors with insights into the perspectives of key individuals within the organization.